Clinical Trials List
2016-02-01 - 2020-07-31
Phase III
Terminated3
ICD-10C66.2
Malignant neoplasm of left ureter
ICD-9198.1
Secondary malignant neoplasm of other urinary organs
-
Trial Applicant
PPD DEVELOPMENT (HK) LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Yeong-Shiau Pu Division of Hematology & Oncology
- YU-CHUAN LU Division of Hematology & Oncology
- JHE-CYUAN GUO Division of Hematology & Oncology
- - - Division of Hematology & Oncology
- - - Division of Hematology & Oncology
- Ying-Chun Shen Division of Hematology & Oncology
- CHUNG-HSIN CHEN Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- Che-Hung Lin Division of Hematology & Oncology
- Wei-Ching Lin Division of Hematology & Oncology
- Ching-Chan Lin Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 黃俊農 Division of Urology
- Sheng-Chen Wen Division of Urology
- Ching-Chia Li Division of Urology
- Hung-Lung Ke Division of Urology
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
12 participants
-
Global
700 participants
